BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li MM, Zheng YL, Wang WD, Lin S, Lin HL. Neuropeptide Y: An Update on the Mechanism Underlying Chronic Intermittent Hypoxia-Induced Endothelial Dysfunction. Front Physiol 2021;12:712281. [PMID: 34512386 DOI: 10.3389/fphys.2021.712281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao F, Meng Y, Wang Y, Fan S, Liu Y, Zhang X, Ran C, Wang H, Lu M. Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway. Front Pharmacol 2022;13:920977. [DOI: 10.3389/fphar.2022.920977] [Reference Citation Analysis]
2 Zhao F, Lu M, Wang H. Ginsenoside Rg1 ameliorates chronic intermittent hypoxia-induced vascular endothelial dysfunction by suppressing the formation of mitochondrial reactive oxygen species through the calpain-1 pathway. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.07.006] [Reference Citation Analysis]
3 Bolshakova S, Madaeva E, Berdina O, Bugun O, Rychkova L. Biomarkers of endothelial dysfunction as a cardiovascular risk factor in patients obstructive sleep apnea syndrome. Profil med 2022;25:114. [DOI: 10.17116/profmed202225081114] [Reference Citation Analysis]
4 Guan Y, Liu J, Gu Y, Ji X. Effects of Hypoxia on Cerebral Microvascular Angiogenesis: Benefits or Damages? Aging and disease 2022. [DOI: 10.14336/ad.2022.0902] [Reference Citation Analysis]